Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Idun Pharmaceuticals (develops drug candidates to control apoptosis) completed a $22.8mm private placement of preferred stock led by Ventana Capital Management. New investors GeneChem Management, Hambrecht and Quist Capital Management (HQCM), RBC Capital Partners, BioVeda Capital, and Sorrento Associates were joined by returning investors Venrock Associates and Arch Venture Partners.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?